19-1221997-G-C
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000326873.12(STK11):āc.911G>Cā(p.Arg304Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R304Q) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000326873.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK11 | NM_000455.5 | c.911G>C | p.Arg304Pro | missense_variant | 7/10 | ENST00000326873.12 | NP_000446.1 | |
STK11 | NM_001407255.1 | c.911G>C | p.Arg304Pro | missense_variant | 7/9 | NP_001394184.1 | ||
STK11 | NR_176325.1 | n.2178G>C | non_coding_transcript_exon_variant | 8/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK11 | ENST00000326873.12 | c.911G>C | p.Arg304Pro | missense_variant | 7/10 | 1 | NM_000455.5 | ENSP00000324856 | P1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1418520Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 701900
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Peutz-Jeghers syndrome Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Feb 12, 2024 | This variant is considered likely pathogenic. Functional studies indicate this variant impacts protein function [PMID: 10441497, 12552571]. This variant has been reported in multiple individuals with clinical features of gene-specific disease [PMID: 16287113]. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 28, 2023 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg304 amino acid residue in STK11. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9809980, 12865922, 15121768, 17404884). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt STK11 protein function. ClinVar contains an entry for this variant (Variation ID: 428783). This missense change has been observed in individuals with clinical features of Peutz-Jeghers syndrome (PMID: 16287113, 30092773). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 304 of the STK11 protein (p.Arg304Pro). - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 24, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 30092773, 15863673, 35189935, 36033506, 16287113) - |
STK11-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 24, 2024 | The STK11 c.911G>C variant is predicted to result in the amino acid substitution p.Arg304Pro. This variant has been reported in individuals with Peutz-Jeghers syndrome (Aretz et al 2005. PubMed ID: 16287113; Jiang et al 2018. PubMed ID: 30092773). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic/likely pathogenic by multiple submitters in Clinvar (https://www.ncbi.nlm.nih.gov/clinvar/variation/428783/). Another well characterized variant that disrupts this residue has been reported in individuals with Peutz-Jeghers syndrome (p.Arg304Trp) suggesting that variants that disrupt this residue are likely to be disease causing (Boudeau et al 2003. PubMed ID: 12552571; Resta et al 1998. PubMed ID: 9809980). This variant is interpreted as likely pathogenic. - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2020 | The p.R304P pathogenic mutation (also known as c.911G>C), located in coding exon 7 of the STK11 gene, results from a G to C substitution at nucleotide position 911. The arginine at codon 304 is replaced by proline, an amino acid with dissimilar properties. This pathogenic variant has been confirmed to be de novo in patients meeting clinical criteria for PJS as well as in several other families meeting clinical criteria for PJS where the variant segregated with disease (Aretz S et al. Hum. Mutat. 2005; 26:513-9: Jiang YL et al. BMC Med. Genet. 2018 08;19:141; Ambry internal data). In addition, a well characterized mutation affecting the same codon, STK11 p.R304W, has also been reported in patients with PJS (Boudeau J et al. Hum. Mutat. 2003 Feb; 21(2):172). Based on internal structural analysis, this variant is anticipated to result in a significant decrease in structural stability (Ambry internal data; Resta N et al. Cancer Res. 1998 Nov; 58(21):4799-801). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at